Close
Achema middle east
swop processing & packaging

News

European Commission approves Roche’s Xofluza to treat influenza

Roche announced that the EC has approved Xofluza (baloxavir marboxil) for the treatment of uncomplicated influenza in patients aged 12 years and above. In addition,...

Dr. Reddy’s Laboratories announces the launch of Febuxostat Tablets in the U.S. Market

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) announced the launch of Febuxostat Tablets, a therapeutic equivalent generic version...

Blackfrog Technologies Emvolio to provide portable active cooling for last-mile transport of vaccines

Portable medical-grade refrigerator as a vial and vaccine carrier enables geo-tagging and mapping delivery routes and assists the distributors to plan their vaccination drive to...

ICON supports Pfizer and BioNTech on the investigational COVID-19 vaccine trial

ICON plc,a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries and government and public...

CEVEC Pharma grants Biogen rights to its proprietary Elevecta Technology for manufacturing of gene therapy products

CEVEC Pharmaceuticals GmbH announced the signing of a license agreement with Biogen Inc. for the use of CEVEC’s proprietary ELEVECTA® Technology for the manufacturing of...

Bharat Biotech gearing up to conduct phase-1 trials for its new intranasal vaccine for Covid-19

Encouraged by the recent approval by Drug Control General of India (DCGI) for its Covid-19 vaccine, Bharat Biotech is now gearing up for conducting the...

Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors

Kite, a Gilead Company, and Oxford BioTherapeutics Ltd. (OBT), a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »